clinical 1,170 words KG: A 6-month & 18-month Prospective, Randomized, Placebo-controlled, Double-blin... (NCT06709014)
Contents

A 6-month & 18-month Prospective, Randomized, Placebo-controlled, Double-blin... (NCT06709014)

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (26)

Heat Shock Protein 70 Disaggregase Amplification
Score: 0.62
Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics
Score: 0.62
Synaptic Vesicle Tau Capture Inhibition
Score: 0.58
HSP90-Tau Disaggregation Complex Enhancement
Score: 0.57
Trans-Synaptic Adhesion Molecule Modulation
Score: 0.54
Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.51
← Prevpg 2/2

Related Analyses (3)

Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed

Related Experiments (1)

Cytochrome Therapeutics
clinical · proposed · Score: 0.40

See Also (15)

Section 194: Advanced Mitochondrial Dynamics and Biogen
therapeutic · Pages share 5 hypotheses
Synaptic Therapy Alzheimer's Research Trial (START): A
clinical · Pages share 5 hypotheses
A Phase 2 Double-Blind, Randomized, Placebo-Controlled
clinical · Pages share 5 hypotheses
Mitochondrial Replacement Therapy for Neurodegeneration
therapeutic · Pages share 5 hypotheses
Mitochondrial Biogenesis Inducers in Neurodegeneration
therapeutic · Pages share 5 hypotheses

Knowledge Graph (1 edges)

A 6-month & 18-month Prospective, Randomized, Placebo-controlled, Double-blin... (NCT06709014) references BACE1

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.